- Home
- SGMO vs MPA Comparison
SGMO vs MPA Comparison
Compare SGMO & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- MPA
- Stock Information
- Founded
- SGMO 1995
- MPA 1992
- Country
- SGMO United States
- MPA United States
- Employees
- SGMO N/A
- MPA N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- MPA Finance Companies
- Sector
- SGMO Health Care
- MPA Finance
- Exchange
- SGMO Nasdaq
- MPA Nasdaq
- Market Cap
- SGMO 180.5M
- MPA 160.3M
- IPO Year
- SGMO 2000
- MPA N/A
- Fundamental
- Price
- SGMO $1.96
- MPA $12.04
- Analyst Decision
- SGMO Buy
- MPA
- Analyst Count
- SGMO 3
- MPA 0
- Target Price
- SGMO $7.00
- MPA N/A
- AVG Volume (30 Days)
- SGMO 11.1M
- MPA 25.2K
- Earning Date
- SGMO 11-12-2024
- MPA 01-01-0001
- Dividend Yield
- SGMO N/A
- MPA 3.83%
- EPS Growth
- SGMO N/A
- MPA N/A
- EPS
- SGMO N/A
- MPA N/A
- Revenue
- SGMO $52,291,000.00
- MPA N/A
- Revenue This Year
- SGMO N/A
- MPA N/A
- Revenue Next Year
- SGMO $71.79
- MPA N/A
- P/E Ratio
- SGMO N/A
- MPA N/A
- Revenue Growth
- SGMO N/A
- MPA N/A
- 52 Week Low
- SGMO $0.30
- MPA $9.87
- 52 Week High
- SGMO $3.18
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- SGMO 51.89
- MPA 42.82
- Support Level
- SGMO $1.82
- MPA $12.10
- Resistance Level
- SGMO $2.11
- MPA $12.15
- Average True Range (ATR)
- SGMO 0.38
- MPA 0.13
- MACD
- SGMO -0.10
- MPA 0.01
- Stochastic Oscillator
- SGMO 16.44
- MPA 27.87
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.